Lipid Droplet Isolation and Proteomics
The Problem With the Fraction
Droplets are less dense than all other organelles, which makes them separable — and also makes them a sink for anything that co-floats: membranes, aggregated protein, vesicles and, in some protocols, the solubilised lipids themselves.
| Contaminant | Marker | Consequence |
|---|---|---|
| Endoplasmic reticulum | Calnexin, PDI, Sec61 | The largest source, because droplets originate there |
| Mitochondria | VDAC, COXIV, TOM20 | Contacts make this worse |
| Plasma membrane | Na/K-ATPase, cadherin | Vesicle entrapment |
| Cytosol | GAPDH, tubulin | Incomplete washing |
| Lysosome and autophagosome | LAMP1, LC3 | Genuine contacts, or contamination |
| Aggregated protein | — | Co-floats; not separable by density |
Important distinction. A protein present in the droplet fraction is not thereby a droplet protein. Enrichment relative to the starting homogenate, and the contamination profile, are what convert a list of proteins into a claim. The ER markers matter most: droplet biogenesis occurs at the ER, so a genuine droplet proteome will contain some ER proteins, and the fraction of ER marker enrichment determines how much of the rest is interpretable.
Part 1 — The Isolation
| Step | Detail | Failure mode |
|---|---|---|
| Lysis | Hypotonic, with a protease and phosphatase inhibitor cocktail | Incomplete lysis retains intact cells |
| Homogenisation | Dounce, gentle, with a nuclei pelleting step | Shear disrupts droplets; over-homogenisation fragments membranes |
| Gradient | Sucrose or iodixanol, typically 0.5–1.0 M bottom layer and low-density top | Wrong density loses droplets or co-isolates membranes |
| Ultracentrifugation | 100,000 × g, 1–2 h, 4 °C | Temperature and time affect recovery |
| Collection | Top fraction, minimal volume | Mixing the interface brings contaminants |
| Washing | Repeat flotation once | Repeated washing loses droplets and surface proteins |
Caveat on iodixanol versus sucrose. Iodixanol gradients give better separation of droplets from ER membranes in many hands, and are less likely to cause osmotic shrinkage. Sucrose is the historical standard. Whichever is used, the density of the droplet layer should be verified rather than assumed, and the marker profile reported.
Part 2 — Validating the Fraction
| Check | Method | Expected |
|---|---|---|
| Droplet presence | Triglyceride content; BODIPY on an aliquot | Enriched relative to homogenate |
| ER contamination | Calnexin immunoblot | Present but not dominant |
| Mitochondrial contamination | VDAC immunoblot | Low in a clean preparation |
| Cytosolic contamination | GAPDH immunoblot | Low |
| Protein yield | BCA or similar | Recorded; low yield means losses |
| Morphology | Electron microscopy | Intact droplets, minimal vesicle contamination |
Readout note. Reporting the immunoblot profile of three or four markers alongside the proteomics data takes an afternoon and is the difference between a dataset that can be interpreted and one that cannot. Reviewers increasingly ask for it, and the papers that lack it are the ones that fail replication.
Part 3 — Proteomics Design
| Decision | Options | Consequence |
|---|---|---|
| Quantification | Label-free, TMT, SILAC | Label-free is common; TMT gives better multiplexing |
| Comparison | Droplet fraction versus homogenate | Enrichment, not abundance |
| Replicates | At least three biological | One preparation cannot distinguish a protein from a contaminant |
| Filtering | Exclude proteins also enriched in a control membrane fraction | Reduces false positives |
| Validation | Imaging or immunoblot for selected hits | Required for any functional claim |
| Reporting | Full list with enrichment values and contamination profile | Allows comparison between studies |
Caveat on "the droplet proteome". Published droplet proteomes differ substantially in size, from a few hundred to several thousand proteins, and the differences track the preparation method as much as the biology. This is why the isolation protocol, the gradient and the filtering criteria belong in the paper rather than in a supplement.
Part 4 — From List to Claim
| Claim | Requires | Not sufficient |
|---|---|---|
| "Protein X localises to droplets" | Enrichment plus imaging in intact cells | Proteomics detection |
| "Protein X is a droplet protein" | Imaging, plus a functional or binding readout | Localisation alone |
| "Droplet composition changed" | Quantitative comparison across conditions, with contamination markers constant | A list from treated cells |
| "Protein X recruits Y to droplets" | Perturbation of X with Y localisation measured | Co-occurrence in a list |
Important distinction. Localisation is not function. A protein detected on droplets may be there for degradation, for storage, or incidentally. The functional claim requires its own experiment, and the proteomics is a hypothesis generator for that experiment, not a substitute for it.
Part 5 — Common Failures
- • No contamination markers reported.
- • Single preparation used for a proteome list.
- • Detergent in the lysis buffer, which dissolves droplets.
- • Over-homogenisation, fragmenting droplets and co-isolating membranes.
- • Gradient density assumed rather than verified.
- • Enrichment not computed, so abundance and localisation are conflated.
- • A proteome list presented as a functional finding.
- • Conditions compared without re-checking the contamination profile, which may itself have changed.
Part 6 — Where This Article Connects
This is the proteomics companion to the droplet biology article, which covers perilipins and turnover. It connects to the phospholipid article for membrane contamination, to the triglyceride assay for fraction validation, and to the imaging articles in this cluster, which supply the localisation confirmation that proteomics cannot.
If you need droplet fractions with validated contamination profiles and imaging confirmation of hits, we can scope the study with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Isolation efficiency, contamination and protein recovery vary with cell type, gradient and homogenisation; the protocol should be reported in enough detail to be reproduced.
Detection in a droplet fraction does not establish localisation in intact cells, and localisation does not establish function.
Scientific interpretation and experimental design
- • The ER is the main contaminant. Droplets come from it.
- • Report markers. Three blots, one afternoon, most of the credibility.
- • Enrichment, not abundance. Compare with homogenate.
- • Three biological replicates minimum.
- • No detergent in lysis. It dissolves the object.
- • Proteomics generates hypotheses. Imaging and perturbation test them.
Selected references for further reading
- • Brasaemle DL, Wolins NE. Isolation of lipid droplets from cells by density gradient centrifugation. Current Protocols in Cell Biology. 2016;72:3.15.1–3.15.13.
- • Bersuker K, et al. A proximity labeling strategy provides insights into the composition and dynamics of lipid droplet proteomes. Developmental Cell. 2018;44:97–112.
- • Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nature Reviews Molecular Cell Biology. 2019;20:137–155.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »